Insmed Incorporated — Cash Flow (NASDAQ:INSM) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities 219.35 M363.3 M400.44 M536.25 M683.88 M935.01 M 935.01 M Cash from investing activities 6.82 M64.28 M34.58 M223.6 M583.17 M64.58 M 64.58 M Cash from financing activities 271 M612.55 M793.27 M168.44 M1.34 B954.07 M 954.07 M Free cash flow 212.53 M356.01 M390.56 M522.96 M661.96 M902.45 M 902.45 M

뉴스

Insmed CEO 루이스, 160만 달러 상당 자사주 매각

Insmed chair and CEO Lewis sells $1.6m in stock

H.C. 웨인라이트, Insmed에 ’매수’ 의견 재확인, 목표가 $230

H.C. Wainwright reiterates Buy on Insmed stock, $230 target

Insmed Lags on Q4 Earnings, Stock Gains on 2026 Brinsupri Sales View

Insmed Incorporated 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:INSM) 2026-02-20

Insmed, BRINSUPRI 출시 성공에 힘입어 2026년 매출 139% 성장 전망

Insmed (INSM) Reports Q4 Loss, Lags Revenue Estimates

Insmed Q4 실적 에상치보다 저조, 수익 예상치를 넘어

Insmed earnings missed by $0.37, revenue topped estimates

Walmart, Southern Co, Newmont Mining and more set to report earnings Thursday

Insmed earnings up next: Can Brinsupri sustain blockbuster start?